Postmenopausal women more often have sleep-onset insomnia disorder and are more likely to screen positive for obstructive sleep apnea, according to a study published online in Menopause.
Amgen and UCB have announced the US Food and Drug Administration (FDA) approval of Evenity (romosozumab) for osteoporosis in postmenopausal women at high risk for fracture.
Postmenopausal women with persistent vasomotor symptoms (VMS) have an increased incidence of breast cancer, according to a study published online Dec. 28 in Menopause.....